Backache & Muscle Relief Drug Recalled for cGMP Deviations
Ultra Seal Corporation is recalling Backache & Muscle Relief packets nationwide due to cGMP (current Good Manufacturing Practice) deviations. The recall affects approximately 5.1 million packets distributed across the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II, which typically warrants a score of 2–4. However, the source explicitly identifies the hazard as cGMP deviations (a manufacturing-process deviation) with no reported illnesses, injuries, or product-quality failures described. This is a precautionary manufacturing-compliance recall without reported harm, placing it at the lower end of the Class II range.
Plain-English summary
Ultra Seal Corporation is voluntarily recalling Backache & Muscle Relief, a pain-relief medication containing acetaminophen 250 mg, magnesium salicylate-tetrahydrate 290 mg, and caffeine 50 mg per 2-tablet packet. The product is manufactured for First Aid Direct, Mason, OH. The recall was initiated on January 24, 2022, due to cGMP deviations identified during manufacturing.
Approximately 5,107,565 packets were distributed nationwide within the United States. Affected lots and expiration dates include: Lot K9770 and AK9770 (Exp. 08/2022); AK9958 and K9958 (Exp. 12/2022); AK9717 (Exp. 07/2022); AK9522 and AK9641 (Exp. 03/2022); and AK9817 (Exp. 09/2022). The product is identified by NDC 42961-111-832.
Consumers who have purchased this product should stop using it and consult their healthcare provider if they have taken it. The recall was classified as FDA Class II and was terminated on October 16, 2023.
The recalled product
- Product
- Backache & Muscle Relief (acetaminophen 250 mg, magnesium salicylate-tetrahydrate 290mg, caffeine 50 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040, NDC 42961-111-832
- Manufacturer
- Ultra Seal Corporation
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot #: K9770
- AK9770 Exp. Date 08/2022
- AK9958
- K9958 Exp. Date 12/2022
- AK9717
- Exp. Date 07/2022
- AK9522
- AK9641
- Exp. Date 03/2022
- AK9817
- Exp. Date 09/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27